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Background: Respiratory symptoms in adulthood have been found to be associated with
childhood respiratory infection, but few studies have analyzed adult bronchial respon-
siveness (BHR) with adequate adjustment for known risk factors.
Objective: To estimate the relation of BHR with serious childhood respiratory infections in
a large population study.
Methods: The European Community Respiratory Health Survey (ECRHS) was a cross-
sectional population-based survey in 34 centers. Data on serious respiratory infections
before the age of 5 years and possible confounders were obtained from a questionnaire
administered in the clinic. Blood samples were taken for measurement of total
immunoglobulin E (IgE) and specific IgE to four common allergens, and spirometry and
bronchial challenge with methacholine were performed. A continuous measure of BHR was
analyzed by multiple regression, in 11,282 participants, in relation to serious respiratory
infection and other potential risk factors, adjusted for center and major determinants of
adult BHR.
Results: Those reporting a serious childhood respiratory infection had greater BHR, by an
amount corresponding to approximately 0.23 doubling doses (95% confidence interval
0.02–0.44) of the amount of methacholine causing a 20% fall (PD20) in forced expiratory
volume in 1 s (FEV1). All childhood factors explained less than 0.3% of variation in BHR in
addition to over 20% by factors measured in adulthood. The relation of BHR to BMI was
confined to smokers.Elsevier Ltd. All rights reserved.
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c.uk (S. Chinn).
ARTICLE IN PRESS
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but this was small in comparison to relations of BHR to IgE-sensitization and airway caliber.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Despite that bronchial responsiveness (BHR) is the objective
measure of choice in epidemiological studies on asthma few
studies have analyzed BHR in relation to childhood respira-
tory infections. One report suggested that a severe
respiratory tract infection in the 1st year of life was a risk
factor for increased BHR 20 years later,1 while another found
raised BHR in 7-year-old children who had four or more
lower respiratory tract infections in the first 3 years of life,
but lower BHR in those who had repeated viral infections.2
Arshad et al.3 found relations between asthma at age 10 and
repeated chest infections at 1 and 2 years of age, but not
with BHR. Go´mez et al.4 reported greater BHR in 71 young
adults who had had viral bronchiolitis in infancy than in 32
controls.
The major risk factors for increased BHR in adulthood are
atopy, smoking and reduced lung function.5,6 In the small
study of Go´mez et al.4 results were unadjusted, while Vonk
et al.1 adjusted for several factors in their analysis of 597
adults, but did not include airway caliber. This report
assesses the relation of severe respiratory tract infection
before the age of 5 years, and other childhood risk factors,
to adult BHR in ECRHS I, taking into account the major
potential confounding factors.
Methods
Subjects
The protocol for ECRHS I has been described in detail.7 In
1991–1993 participating centers studied an area defined by
pre-existing administrative boundaries, with a population of
at least 150,000 people. A sampling frame was used to select
randomly at least 1500 men and 1500 women aged 20–44
years, who were sent a self-completed postal questionnaire.
A random sample of responders was invited to stage 2, which
included an administered questionnaire, measurement of
lung function, and both blood sampling and bronchial
challenge in 34 centers. Ethical approval was obtained for
each center from the appropriate ethics committee, and
written consent was obtained from each participant.
Questionnaire data
The question ‘Did you have a serious respiratory infection
before the age of five years’ was of primary interest. Due to
reported associations with asthma or lung function, number
of siblings and exposure to day care before the age of 5
years,8 pet keeping (cat, dog or bird) in childhood,9 paternal
and maternal smoking in childhood,10 were considered as
variables of secondary interest, as was current pet keeping
due to possible confounding with childhood exposure. ‘Don’t
know’ was an accepted answer to childhood questions otherthan those about pet-keeping. Participants were divided
into never smokers, ex-smokers and current smokers based
on answers to the questions ‘Have you ever smoked for as
long as one year?’, and ‘Do you now smoke, as of one month
ago?’. A serious childhood respiratory infection, was
reported to be associated with a family history of allergic
disease, defined as present if the participant reported that
his/her mother father, brothers or sisters had had asthma,
eczema, skin or nasal allergy or hay fever,11 and thus
included in the analysis.
Total and specific immunoglobulin E (IgE)
Serum total IgE and specific IgE to cat, house dust mite (D.
pteronyssinus), Cladosporium and Timothy grass were
measured using the Pharmacia CAP System (Pharmacia
Diagnostics AB, Uppsala, Sweden). The measurement range
for total IgE was 2–2000 kU/L, and 0.35–100 kUA/L for
specific IgE. Sensitization was defined as a specific IgE of
0.35 kUA/L or greater.
BMI
Height and weight were measured in the majority of
centers, self-reported in a few, prior to lung function
measurement. BMI, weight in kilograms divided by the
square of height in meters, was divided into underweight
(o20), normal weight (20 to o25), overweight (25 to o30)
and obese (X30).
Lung function and methacholine challenge
As far as possible clinic appointments were made so that
participants who were taking medication were seen at least
4 h after inhaled medication and at least 8 h after oral
medication. Appointments were made at a time of day
convenient to participants, and it was not possible to
standardize testing by time of day in the young adult
population. Season of testing varied, but was controlled for
in the analysis. The maximum FEV1 of up to five technically
acceptable blows was determined, and similarly for forced
vital capacity (FVC). BHR was measured in eligible subjects
using one of two dosing schedules, one delivering methacho-
line to a maximum dose of 1mg and the other to a maximum
of 2mg. Methacholine was delivered via a Mefar dosimeter
(Mefar, Bovezzo, Italy), FEV1 was recorded 2min after each
inhalation and the test stopped when either a 20% fall in
FEV1 was achieved or the final dose had been given. Only
data from the doses common to the two schedules,
0.0078–1mg cumulative dose, have been used in multi-
center analyses. The measure of dose response ‘slope’
adopted for between center analyses in the ECRHS is used as
the measure of BHR.12,13 As transformed for analysis a low
slope is indicative of high BHR, with values ranging from 1 to
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approximate change in PD20 in doubling dose units using
the conversion factor of two units of slope equal to one of
log PD20 to base 10.
14
Statistical analysis
The association between BHR slope and all childhood and
pet exposure variables was examined as described above,
with adjustment for center, sex, age, smoking, an age-
smoking interaction, height, baseline FEV1, expressed as a
standardized difference from an internally derived pre-
dicted value and as a percentage of FVC, season of testing,
log total IgE and sensitization to four allergens, including
titers as measures of degree of sensitization.12 Interactions
of sensitization with center were included as heterogeneity
was detected in the relations with BHR.12 Number of siblings
was included, as categories 0, 1, 2, 3, 4 or more, and its
interaction with day care before the age of 5 years.8 Pet
keeping in adulthood was categorized into pets allowed in
the house or not, and in the case of cats and dogs further
subdivided into whether allowed in the bedroom or not. The
interaction of serious respiratory infection with family
history of allergic disease was assessed. A smoking–BMI
interaction was investigated in a previous analysis of the
ECRHS I data, as it has been suggested that smoking15 and
obesity16 may each cause asthma, and the interrelations are
complex as smokers tend to gain weight on quitting.17 That
analysis supported inclusion of the interaction in the current
analysis,18 in contrast to the earlier findings.13 In the
multivariable analysis of BHR slope no non-linearity with
BMI was detected, so BMI was therefore treated as
continuous in subsequent analyses, as in the previous
report,13 except for graphical presentation. The sex-BMI
interaction was also assessed. Terms included in a previous
analysis,13,18 the variable of primary interest, i.e. childhoodTable 1 The distribution of childhood risk factors and adult ex
Risk factor No
n (%)
Serious respiratory infection before 5 years 11,053 (85.6)
Did you go to play-school or nursery with older
children before the age of 5 years?
6230 (48.2)
Did your father ever smoke regularly during
your childhood?
4206 (32.5)
Did your mother ever smoke regularly during
your childhood, or before you were born?
9297 (71.8)
Household cat in childhood 6851 (53.0)
Household dog in childhood 6730 (52.1)
Household birds in childhood 7111 (55.0)
Family history of allergic disease 4544 (35.0)
Current pet keeping None or outsid
only
Cat 10,333 (79.9)
Dog 11,033 (85.3)
Birds 11,652 (90.1)
Included not ascertainable due to no siblings or ‘Don’t know’ inrespiratory infection, or other variables with a P-value of
less than 0.1 were retained after backwards selection. The
coefficients of interest in the final model were examined for
between center heterogeneity.19Results
In total 12,975 participants had a BHR slope. The majority of
these had data for the early life variables (Table 1).Elimination of potential risk factors
There was no evidence for an interaction of BMI and sex
(P ¼ 0:57) or of number of siblings and day care (P ¼ 0:46),
or of serious respiratory infection in childhood with family
history of allergic disease (P ¼ 0:70). Variables were
eliminated in order as follows: current cat in house
(P ¼ 0:89); current dog in house (P ¼ 0:74); father smoked
(P ¼ 0:66); day care before the age of five years (P ¼ 0:46);
exposure to bird in childhood (P ¼ 0:47); number of siblings
(P ¼ 0:33); mother smoked (P ¼ 0:32); bird in house
(P ¼ 0:14); exposure to dog in childhood (P ¼ 0:13); and
exposure to cat in childhood (P ¼ 0:18). Hence of the
variables not included in previous analyses only serious
respiratory infection and family history of allergic disease
were retained in the model.Relation of BHR to serious childhood infection
Effect estimates for the childhood risk factors remaining in
the model are shown in Table 2, for 11,282 participants. A
reported serious respiratory infection before the age of 5
years (P ¼ 0:033) was associated with reduced slope,
i.e. increased BHR, compared to no exposure. The inclusionposure to pets in participants with BHR data.
Yes Don’t know Total
n (%) n (%)
1197 (9.3) 661 (5.1) 12,911
6462 (50.0) 237 (1.8) 12,929
8318 (63.2) 427 (3.3) 12,951
3491 (26.9) 168 (1.3) 12,956
6071 (47.0) — 12,922
6197 (47.9) — 12,927
5815 (45.0) — 12,926
6938 (53.5) 1493 (11.5) 12,975
e Allowed indoors,
not in bedroom
Allowed in
bedroom
505 (3.9) 2087 (16.1) 12,925
619 (4.8) 1277 (9.9) 12,929
1275 (9.9) — 12,927
parents.
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Table 2 Mean difference in BHR slope by exposure to serious respiratory infection before the age of 5 years and family
history of allergy.
Risk factor Difference in mean
slope from no
exposure
95% confidence
interval for
difference
P-value for
difference from
reference group
P-value for any
difference
Serious respiratory infection 0.14 0.26 to 0.01 0.033 0.070
Serious respiratory
infection—’don’t know’
0.09 0.26 to 0.08 0.288
Family history of allergic
disease
0.12 0.20 to 0.04 0.004 0.015
Family
history—unascertainable or
‘don’t know’
0.06 0.18 to 0.07 0.373
Estimates are mutually adjusted, and also adjusted for center, sex, IgE sensitization with center interactions, log total IgE, height,
baseline FEV1 as difference from predicted, FEV1/FVC, height, season of testing, age, smoking status, BMI, and age/smoking and
smoking/BMI interactions, after backwards stepwise multiple regression.
S. Chinn et al.986of the ‘don’t know’ category for serious respiratory
infection reduced the overall significance (P ¼ 0:070).Major adult determinants of BHR
The previously considered risk factors, IgE sensitization and
degree of sensitization with interactions with center, FEV1,
FEV1/FVC, height, sex, season of testing smoking and its
interactions with age and BMI, together explained 24.2% of
the variation in BHR slope. Adding all the other factors
considered, reported serious respiratory infection or at-
tended daycare before the age of 5, family history of
allergic disease, parental smoking, exposure to pets in
childhood or currently, explained an additional 0.2%. The
adjusted R2 values were 0.220 and 0.221, respectively. With
adjustment for childhood respiratory infection, and family
history of allergy, between center heterogeneity in the
relations of IgE sensitization to each allergen was still
present, and log total IgE, FEV1 as difference from predicted
and as percentage of FVC, and height each remained
strongly associated with BHR. Women had lower mean
slope, i.e. greater BHR, than men (Po0.001). There was no
association of BHR with season of testing. The differences in
trend of BHR with BMI between the three smoking groups
were marginally statistically significant (P ¼ 0:086), with
virtually no trend in non-smokers (P ¼ 0:45) and negative
trends of slope with BMI in ex-smokers and current smokers.
The difference in trend with BMI from non-smokers was
similar in ex-smokers and smokers, so these groups were
combined. The estimates in approximate doubling doses of
PD20 in Table 3 show a statistically significant difference
(P ¼ 0:039) in trend with BMI between ever smokers and
never smokers. It also shows that mean BHR between those
reporting a serious respiratory infection in childhood was
greater by approximately only 0.29 doubling doses of PD20
than those reporting no such infection (95% confidence
interval 0.44 to 0.02). The interaction of age and
smoking status was not statistically significant (P ¼ 0:50),
and was omitted in the Table 3 model. These differences in
the models in Tables 2 and 3 had little effect on the P-valuesassociated with serious respiratory infection before the age
of 5 years or family history of allergic disease, as shown.
No heterogeneity between centers was detected for any
of the estimates in Table 3. The interaction between BMI and
smoking was re-estimated treating BMI as categorical, and
shown in Fig. 1, overweight and obese smokers having lower
mean approximate PD20, i.e. increased BHR, compared to
other groups.Discussion
This analysis has shown a weak, but positive, relation
between reported serious childhood respiratory infection
and increased BHR. The difference in mean BHR between
those reporting serious childhood respiratory infection and
those who did not was small, corresponding to 0.2 doubling
doses PD20, approximately. The observed effect may be an
underestimate, for two reasons. Some misclassification of
childhood infections is likely, due to error in recalling an
early childhood event as a young adult. Second, in common
with most studies relying on recall, we were unable to
differentiate between lower and upper respiratory tract
infections, or between bacterial and viral infections. Using
data from a longitudinal birth cohort Illi et al.2 found
opposite effects of lower respiratory tract infections and
repeated viral infections in the first 3 years of life, on BHR at
age 7 years, so effects of the former may be diluted by the
latter in the ECRHS. Arshad et al. analyzed recurrent chest
infections, i.e. more than one in a year, in the first 4 years of
life, finding no relation to BHR at age 7 years.3
Only three studies have previously analyzed childhood
infections in relation to adult BHR.1,4,11 Vonk et al.1 found a
very strong relation of BHR to serious doctor-treated
respiratory tract infection in the 1st year of life, in atopic
and non-atopic young adults in Groningen. Atopy was
defined as a positive skin prick test to any one of several
allergens. From our previous analyses of ECRHS data this is
not sufficient to represent the relation of BHR to atopy, the
relation varying between different allergens and with
degree of IgE sensitization,12 and they did not adjust for
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Table 3 Relation of BHR in approximate doubling dose units of PD20 to exposure to serious respiratory infection before the
age of 5 years, family history of allergic disease and difference in trend with BMI in ever smokers compared to non-smokers.
Risk factor Estimate (DD PD20)
 95% confidence interval
for difference
(DD PD20)
P-value for
difference from
reference group
P-value for any
difference
Serious respiratory
infection: difference from
‘no’
0.23 0.44 to 0.02 0.031 0.064
Serious respiratory
infection—’don’t know’:
difference from ‘no’
0.15 0.43 to 0.12 0.276
Family history of allergic
disease: difference from
‘no’
0.20 0.33 to 0.06 0.004 0.016
Family
history—unascertainable or
‘don’t know’: difference
from ‘no’
0.10 0.30 to 0.11 0.360
Trend with BMI—difference
between ever-smokers and
non-smokers
0.03 0.07 to 0.00 0.039
Estimates are mutually adjusted, and also adjusted for center, sex, IgE sensitization with center interactions, log total IgE, height,
baseline FEV1 as difference from predicted, FEV1/FVC, height, season of testing, age, smoking status and trend with BMI in non-
smokers.
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Figure 1 Mean difference in BHR from normal weight
participants in non-smokers ______ and ever-smokers —————
in approximate doubling dose units of PD20, adjusted for sex,
age, IgE sensitization with center interactions, log total IgE,
height, baseline FEV1 as difference from predicted, FEV1/FVC,
height, season of testing, reported serious respiratory illness in
first 5 years and family history of allergic disease.
Adult bronchial responsiveness and childhood illness 987airway caliber or BMI. In three centers of the ECRHS no
statistically significant relation between current asthma or
BHR was found with serious respiratory infection in child-
hood,11 but in this smaller sample, and with BHR dichot-
omized, less adjustment for confounding was possible, and
less power available. The results of Go´mez et al.4 wereunadjusted for other risk factors, and hence hard to
interpret.
Although the ECRHS has the weakness that we cannot be
sure of the exact nature of ‘a serious respiratory infection in
the first 5 years’, it has a number of strengths. BHR as a
continuous outcome was analyzed for over 11,000 people,
while other studies included less than 1000 in multivariable
analyses of dichotomized BHR, and therefore with less
power on two counts. The ECRHS analysis enabled inclusion
of major risk factors for BHR, possible interactions, and
testing of heterogeneity between the 34 centers. Although
small, and weakly statistically significant, the relation of
BHR to early respiratory infection was consistent across the
centers, and robust to inclusion or exclusion of other
potential childhood risk factors.
A number of studies, including the ECRHS, have studied
adult asthma in relation to other childhood risk factors. In
the ECRHS symptoms of asthma were associated with
parental smoking, and with maternal smoking in preg-
nancy,10 and number of siblings and day care attendance
before the age of 5.8 Cat-owning in childhood was associated
with asthma in atopic participants, while dog-keeping was
associated with asthma in non-atopic people.9 A weak
increase in BHR with cat exposure and weak decrease with
dog exposure in childhood were not included in the final
models in this paper. De Meer et al.20 found cat owning
before the age of 18 years to be negatively associated with
asthma, and with BHR, although the latter was not
statistically significant in the small sample studied.
The first 5 years of life are a time characterised by
multiplication and growth of bronchi and alveoli. Although
the number of alveoli are largely determined in the first 2
years of life, and bronchi do not ‘multiply’ after the first 16
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Lower airway infections during this critical period of lung
development appear to increase bronchial responsiveness,
which may be carried over to adult life. Two cohort studies
have found adult lung function to be lower in those who
experienced pneumonia in early childhood.22,23 In the larger
of these studies lung function was also reduced, to a lesser
extent, in those who had had whooping cough.22 Hence early
childhood infections may increase BHR through reducing
lung function in addition to a direct effect. Although we
adjusted for FEV1 and FEV1/FVC, and showed in a previous
analysis that results were independent of how adjustment
for lung function was made,13 we cannot totally rule out
residual confounding of lung function accounting for the
relation of BHR to reported serious respiratory infection in
the first 5 years.
A previous analysis of the ECRHS data suggested that BHR
was positively associated with BMI.13 However in that paper
we did not investigate a smoking-BMI interaction, in
common with previous authors on the subject of asthma
and obesity, and later found that the relation of BHR to BMI
was confined to smokers and ex-smokers.18 Although the
statistical significance of the interaction term was not
strong it is nevertheless true that had we included it in the
original analysis we would have drawn a different conclu-
sion. In adults the evidence for a positive relation between
BHR and BMI is weak.
Childhood respiratory illness has been shown to be
associated with increased BHR in adulthood but effects are
small in comparison to those of IgE-sensitization, airway
caliber and smoking, and will only be detected in large
epidemiological studies.
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